Buchumschlag

Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR

Patients after transcatheter aortic valve replacement (TAVR) are at increased risk of both major adverse cardiac events (MACE), including ischemic and thrombotic complications, as well as significant bleeding. Given this delicate balance between prothrombotic and hemorrhagic risk, the assessment of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hesselbarth, David (VerfasserIn) , D’Orazio, Michelle (VerfasserIn) , Ciccarone, Giovanni (VerfasserIn) , Gjermeni, Diona (VerfasserIn) , Jülch, Carina (VerfasserIn) , Wessinger, Marius (VerfasserIn) , Maslarska, Mariya (VerfasserIn) , Rilinger, Jonathan (VerfasserIn) , Hilgendorf, Ingo (VerfasserIn) , Wolf, Dennis (VerfasserIn) , Kaier, Klaus (VerfasserIn) , Dürschmied, Daniel (VerfasserIn) , Pottgiesser, Torben (VerfasserIn) , von zur Mühlen, Constantin (VerfasserIn) , Westermann, Dirk (VerfasserIn) , Olivier, Christoph B. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 2025
In: Clinical research in cardiology
Year: 2025, Jahrgang: 114, Heft: 11, Pages: 1606-1615
ISSN:1861-0692
DOI:10.1007/s00392-025-02749-7
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00392-025-02749-7
Volltext
Verfasserangaben:David Hesselbarth, Michelle D’Orazio, Giovanni Ciccarone, Diona Gjermeni, Carina Jülch, Marius Wessinger, Mariya Maslarska, Jonathan Rilinger, Ingo Hilgendorf, Dennis Wolf, Klaus Kaier, Daniel Duerschmied, Torben Pottgiesser, Constantin von zur Mühlen, Dirk Westermann, Christoph B. Olivier

MARC

LEADER 00000naa a2200000 c 4500
001 1944401385
003 DE-627
005 20251204094839.0
007 cr uuu---uuuuu
008 251204s2025 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00392-025-02749-7  |2 doi 
035 |a (DE-627)1944401385 
035 |a (DE-599)KXP1944401385 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hesselbarth, David  |d 1988-  |e VerfasserIn  |0 (DE-588)1223664236  |0 (DE-627)1743136390  |4 aut 
245 1 0 |a Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR  |c David Hesselbarth, Michelle D’Orazio, Giovanni Ciccarone, Diona Gjermeni, Carina Jülch, Marius Wessinger, Mariya Maslarska, Jonathan Rilinger, Ingo Hilgendorf, Dennis Wolf, Klaus Kaier, Daniel Duerschmied, Torben Pottgiesser, Constantin von zur Mühlen, Dirk Westermann, Christoph B. Olivier 
264 1 |c November 2025 
300 |b Diagramme 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 6. Oktober 2025 
500 |a Gesehen am 04.12.2025 
520 |a Patients after transcatheter aortic valve replacement (TAVR) are at increased risk of both major adverse cardiac events (MACE), including ischemic and thrombotic complications, as well as significant bleeding. Given this delicate balance between prothrombotic and hemorrhagic risk, the assessment of hemostatic markers might help identify patients at increased risk. 
650 4 |a Hemostatic markers 
650 4 |a TAVR 
650 4 |a TEG 
650 4 |a Thrombelastography 
650 4 |a Transcatheter aortic valve replacement 
700 1 |a D’Orazio, Michelle  |e VerfasserIn  |4 aut 
700 1 |a Ciccarone, Giovanni  |e VerfasserIn  |4 aut 
700 1 |a Gjermeni, Diona  |e VerfasserIn  |4 aut 
700 1 |a Jülch, Carina  |e VerfasserIn  |4 aut 
700 1 |a Wessinger, Marius  |e VerfasserIn  |4 aut 
700 1 |a Maslarska, Mariya  |e VerfasserIn  |4 aut 
700 1 |a Rilinger, Jonathan  |e VerfasserIn  |4 aut 
700 1 |a Hilgendorf, Ingo  |e VerfasserIn  |4 aut 
700 1 |a Wolf, Dennis  |e VerfasserIn  |4 aut 
700 1 |a Kaier, Klaus  |e VerfasserIn  |4 aut 
700 1 |a Dürschmied, Daniel  |d 1976-  |e VerfasserIn  |0 (DE-588)129152196  |0 (DE-627)390022462  |0 (DE-576)187844623  |4 aut 
700 1 |a Pottgiesser, Torben  |e VerfasserIn  |4 aut 
700 1 |a von zur Mühlen, Constantin  |e VerfasserIn  |4 aut 
700 1 |a Westermann, Dirk  |e VerfasserIn  |4 aut 
700 1 |a Olivier, Christoph B.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical research in cardiology  |d Berlin : Springer, 2006  |g 114(2025), 11 vom: Nov., Seite 1606-1615  |h Online-Ressource  |w (DE-627)506287343  |w (DE-600)2218331-0  |w (DE-576)251097692  |x 1861-0692  |7 nnas  |a Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR 
773 1 8 |g volume:114  |g year:2025  |g number:11  |g month:11  |g pages:1606-1615  |g extent:10  |a Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR 
856 4 0 |u https://doi.org/10.1007/s00392-025-02749-7  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251204 
993 |a Article 
994 |a 2025 
998 |g 129152196  |a Dürschmied, Daniel  |m 129152196:Dürschmied, Daniel  |d 60000  |d 61000  |e 60000PD129152196  |e 61000PD129152196  |k 0/60000/  |k 1/60000/61000/  |p 12 
999 |a KXP-PPN1944401385  |e 4821380013 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1944401385"],"doi":["10.1007/s00392-025-02749-7"]},"relHost":[{"disp":"Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVRClinical research in cardiology","part":{"issue":"11","year":"2025","text":"114(2025), 11 vom: Nov., Seite 1606-1615","pages":"1606-1615","extent":"10","volume":"114"},"title":[{"title_sort":"Clinical research in cardiology","title":"Clinical research in cardiology"}],"origin":[{"dateIssuedDisp":"2006-","publisherPlace":"Berlin","dateIssuedKey":"2006","publisher":"Springer"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"506287343","pubHistory":["95.2006 -"],"id":{"issn":["1861-0692"],"eki":["506287343"],"zdb":["2218331-0"]}}],"recId":"1944401385","physDesc":[{"noteIll":"Diagramme","extent":"10 S."}],"name":{"displayForm":["David Hesselbarth, Michelle D’Orazio, Giovanni Ciccarone, Diona Gjermeni, Carina Jülch, Marius Wessinger, Mariya Maslarska, Jonathan Rilinger, Ingo Hilgendorf, Dennis Wolf, Klaus Kaier, Daniel Duerschmied, Torben Pottgiesser, Constantin von zur Mühlen, Dirk Westermann, Christoph B. Olivier"]},"language":["eng"],"note":["Online veröffentlicht: 6. Oktober 2025","Gesehen am 04.12.2025"],"title":[{"title_sort":"Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR","title":"Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR"}],"origin":[{"dateIssuedDisp":"November 2025","dateIssuedKey":"2025"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"family":"Hesselbarth","display":"Hesselbarth, David","given":"David","role":"aut"},{"display":"D’Orazio, Michelle","family":"D’Orazio","given":"Michelle","role":"aut"},{"role":"aut","given":"Giovanni","display":"Ciccarone, Giovanni","family":"Ciccarone"},{"display":"Gjermeni, Diona","family":"Gjermeni","role":"aut","given":"Diona"},{"role":"aut","given":"Carina","display":"Jülch, Carina","family":"Jülch"},{"role":"aut","given":"Marius","display":"Wessinger, Marius","family":"Wessinger"},{"family":"Maslarska","display":"Maslarska, Mariya","role":"aut","given":"Mariya"},{"given":"Jonathan","role":"aut","display":"Rilinger, Jonathan","family":"Rilinger"},{"role":"aut","given":"Ingo","family":"Hilgendorf","display":"Hilgendorf, Ingo"},{"given":"Dennis","role":"aut","family":"Wolf","display":"Wolf, Dennis"},{"role":"aut","given":"Klaus","display":"Kaier, Klaus","family":"Kaier"},{"given":"Daniel","role":"aut","display":"Dürschmied, Daniel","family":"Dürschmied"},{"display":"Pottgiesser, Torben","family":"Pottgiesser","role":"aut","given":"Torben"},{"given":"Constantin","role":"aut","display":"von zur Mühlen, Constantin","family":"von zur Mühlen"},{"family":"Westermann","display":"Westermann, Dirk","role":"aut","given":"Dirk"},{"family":"Olivier","display":"Olivier, Christoph B.","role":"aut","given":"Christoph B."}]} 
SRT |a HESSELBARTFIBRINCLOT2025 

Ähnliche Einträge